The Latest Breaking News from FDA

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

U.S. officials halted Verve's plan to begin testing in people a gene-editing approach to high cholesterol, leading VERV stock to crash.

The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him

Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.

Colorado voters are set to decide whether to decriminalize psychedelic mushrooms for those 21 and older and create state-regulated “healing centers” where participants can experience the drug

WASHINGTON — Five states will vote next week on whether to join the 21 states and territories that have legalized recreational marijuana for adults. But the federal government is still stuck on whether to remove the plant from Schedule I of the federal drug code — a category reserved for…

Reflexive opposition to the 45th president was terrible for Covid policy and basic ethics.